Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
2021 · Nature · 2,066 citations
https://doi.org/10.1038/s41586-021-04385-3
F
Fanchong Jian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
7.6K
Citations
28
h-index
42
i10-index
Fanchong Jian is an academic researcher from Pioneer (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 28, co-authored 59 publications.
ORCID: 0000-0001-8703-3507Papers by this author
worksBA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
2022 · Nature · 1,417 citations
https://doi.org/10.1038/s41586-022-04980-y
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
2022 · bioRxiv (Cold Spring Harbor Laboratory) · 394 citations
https://doi.org/10.1101/2022.09.15.507787
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
2023 · The Lancet Infectious Diseases · 378 citations
https://doi.org/10.1016/s1473-3099(23)00744-2
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
2023 · Nature · 250 citations
https://doi.org/10.1038/s41586-023-06753-7
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
2024 · Nature · 123 citations
https://doi.org/10.1038/s41586-024-08315-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat